In reply [5]

Journal of Clinical Oncology

Volumn 26, Issue 1, 2008, Pages 162-164

  Isacoff, William H ^a   Philip, Philip A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; IRINOTECAN;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; LETTER; LEUKEMIA; MONOTHERAPY; PANCREAS CANCER; PANCREATICODUODENECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; COST OF ILLNESS; HEALTH STATUS; MORTALITY; NEOPLASM; NOTE; PATHOLOGY; QUALITY OF LIFE; SURVIVAL RATE; SURVIVOR;

COST OF ILLNESS; HEALTH STATUS; HUMANS; NEOPLASMS; QUALITY OF LIFE; SURVIVAL RATE; SURVIVORS;

EID: 37849045905     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.0227     Document Type: Letter

References (11)

1. Ben-Josef E, Lawrence TS, Zalupski MM: Radiotherapy for locally advanced pancreatic cancer. J Clin Oncol 25:4861, 2007
2. Isacoff WH, Benedetti JK, Philip PA, et al: Phase II Trial of Infusional Fluorouracil, Leucovorin, Mitomycin-C and Dipyridamole in Locally Advanced Unresectable Pancreatic Adenocarcinoma: SWOG 9700. J Clin Oncol 25:1665-1669, 2007
3. Desai SP, Ben-Josef E, Normolle DP, et al: Phase I: Study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer. J Clin Oncol 25:4587-4592 2007
4. McGinn CJ, Zalupski MM, Shureiqi I, et al: Phase I: Trial of Radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol 19:4202-4208, 2001
5. Blackstock AW, Tepper JE, Niedwiecki D, et al: Cancer and Leukemia Group B (CALGB) 89805: Phase II chemoradiation trial using gemcitabine on patients with locoregional adenocarcinoma of the pancreas. Int J Gastrointestin Cancer 34:107-116, 2003
6. Crane CH, Abbruzzese JL, Evans DB, et al: Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiology Oncology Biol Phys 52:1293-1302, 2002
7. Mishra G, Butler J, Ho C, et al: Phase II trial of induction gemcitabine/cpt-11 followed by twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer. Am J Clin Oncol 28:345-350, 2005
8. Krishnan S, Rana V, Janjan MA, et al: Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 110:47-55, 2007
9. Haddock MG, Swaminathan R, Foster NR, et al: Gemcitabine, cisplatin and radiotherapy for patients with locally advanced pancreatic carcinoma: Results of a North Central Cancer Treatment Group Phase II study N9942. J Clin Oncol 25:2567-2572, 2007
10. Chauffert B, Mornex F, Bonnetain F, et al: Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs gemcitabine alone in patients with locally advanced non-metastatic pancreatic cancer: A FFCD-SFRO study. J Clin Oncol 24:180, 2006
11. Huquet F, André T, Hammel P, et al: Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 25:326-331, 2007